Serum S100A8/S100A9 levels were increased in patients with idiopathic pulmonary fibrosis and acute exacerbation of COPD compared with normal subjects, and negatively associated with pulmonary function (Huang et al. 2020; Tanaka et al. 2021). This evidence concerns the gene S100A9 and pulmonary fibrosis.